コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 retinal OCT parameters and directly measured elevated intracranial pressure.
2 specificity (95% CI, 41%-79%) for detecting elevated intracranial pressure.
3 oportion of successfully treated episodes of elevated intracranial pressure.
4 effective than mannitol for the treatment of elevated intracranial pressure.
5 characterized by decreased host survival and elevated intracranial pressure.
6 Global cerebral ischemia was produced via elevated intracranial pressure.
7 her insight into optic nerve compliance with elevated intracranial pressure.
8 ren often present with signs and symptoms of elevated intracranial pressure.
9 ostflight with ophthalmological findings and elevated intracranial pressure.
10 core, 1.20 (1.13-1.26) for each 5-unit rise; elevated intracranial pressure, 1.75 (1.31-2.33); and as
11 reatment group, fewer episodes of critically elevated intracranial pressure (92 vs. 167, p = .027) in
12 ing of brain infection and can contribute to elevated intracranial pressure, a medical emergency.
13 blood flow, cerebral perfusion pressure, and elevated intracranial pressure after fluid percussion br
14 ny long-duration astronauts develop signs of elevated intracranial pressure and have neuro-ophthalmol
19 invasive screening test for the detection of elevated intracranial pressure and prediction of intracr
20 the first cryptococcal gene associated with elevated intracranial pressure and support the hypothesi
21 travelers at risk, the presence of headache, elevated intracranial pressure, and pleocytosis, with or
22 trasound of the eye has been correlated with elevated intracranial pressure, but optimal cutoffs have
23 be superior to mannitol for the treatment of elevated intracranial pressure, but their impact on clin
24 ildren and young adults with papilledema and elevated intracranial pressure causing vision loss that
26 atory distress syndrome, status asthmaticus, elevated intracranial pressure, elevated intra-abdominal
27 rentially expressed features associated with elevated intracranial pressure events in children with s
28 cranial pressure events; 200 records without elevated intracranial pressure events were used as contr
31 rlapping 30-min analysis windows prior to 21 elevated intracranial pressure events; 200 records witho
32 ure monitoring, and sustained and refractory elevated intracranial pressure for 1 to 12 hours despite
33 , with traumatic brain injury and refractory elevated intracranial pressure (>25 mm Hg) to undergo de
34 ation appears promising for the detection of elevated intracranial pressure, however, verification fr
36 al perfusion pressure (CPP) concomitant with elevated intracranial pressure (ICP) after FPI were grea
38 derlying neonatal retinal hemorrhage include elevated intracranial pressure (ICP) inducing venous out
39 inflammatory syndrome (IRIS), (3) persistent elevated intracranial pressure (ICP) only, or (4) persis
40 ncluding venous transmission of pressure and elevated intracranial pressure (ICP), could explain thes
41 Loss of SPCs leads to skull deformities and elevated intracranial pressure (ICP), whereas transplant
48 m solutions to mannitol for the treatment of elevated intracranial pressure in human subjects undergo
49 ive predictor of progressive or persistently elevated intracranial pressure in newborns with hydrocep
51 ons may lead to neuroanatomic ambiguity, and elevated intracranial pressure is not the most common ca
54 comprising 112 patients with 184 episodes of elevated intracranial pressure met our inclusion criteri
55 umulation in the brain's ventricles, causing elevated intracranial pressure, neurological deficits, a
56 We analyzed the frequency of episodes with elevated intracranial pressure (new anisocoria or intrac
57 s with idiopathic intracranial hypertension, elevated intracranial pressure of other causes and norma
63 ation, ICH due to vascular malformation, and elevated intracranial pressure requiring urgent interven
67 sociation with hypocalcemia, with or without elevated intracranial pressure, which highlights the nec
68 is a neurological disorder characterized by elevated intracranial pressure without definitive etiolo